How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
News|Articles|April 25, 2018
GRAM Adds Vial Filling Line
Author(s)Pharmaceutical Technology Editors
Grand River Aseptic Manufacturing announces equipment purchase to add vial filling capacity.
Advertisement
Grand River Aseptic Manufacturing, Inc. (GRAM), a parenteral contract development and manufacturing organization, announced on April 24, 2018 the purchase of a Bausch+Ströbel high-speed filling line with SKAN isolator, marking the second major equipment purchase of the year. In March 2018, the company previously announced the purchase of a new syringe filler and a land purchase agreement to acquire a 1.5-acre lot in Grand Rapids, MI.
The filling line can fill 200 vials per minute, which will more than triple the company’s manufacturing capacity, according to a press statement. The integrated fill line includes a vial washer, depyrogenation tunnel, and filling machine and the capacity to fill vials ranging from 2mL–50mL with 100% weight checks.
The company noted that it is reinvesting in the development of clinical-scale manufacturing.
Source:
Advertisement
Related to this article
BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
2
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
5